תוצאות חיפוש - Ruth Oliver

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease

    Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease מאת Janet R. Wade, Adwoa Parker, Gordana Kosutic, Brian G. Feagen, William J. Sandborn, Christian Laveille, Ruth Oliver

    יצא לאור 2015
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects

    Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects מאת Ruth Dixon, Sarah A. Job, Ruth Oliver, Debra Tompson, John G. Wright, Kay Maltby, Ulrike Lorch, Jörg Täubel

    יצא לאור 2008
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

    Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F מאת Ralph Adams, Asher Maroof, Terry Baker, Alastair D. G. Lawson, Ruth Oliver, Ross A. Paveley, Steve Rapecki, Stevan Shaw, Pavan Vajjah, Shauna West, Meryn Griffiths

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia

    Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia מאת Esther E. Bron, Rebecca M. E. Steketee, J. Graeme Houston, Ruth Oliver, Hakim C. Achterberg, Marco Loog, John C. van Swieten, Alexander Hammers, Wiro J. Niessen, Marion Smits, Stefan Klein

    יצא לאור 2014
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

    Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F co... מאת Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu, Alastair D. G. Lawson, Ash Maroof, Ruth Oliver, Serghei Popa, Foteini Strimenopoulou, Pavan Vajjah, Mark Watling, Nataliya Yeremenko, Pierre Miossec, Stevan Shaw

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study*

    Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐... מאת Ruth Oliver, James G. Krueger, Sophie Glatt, Pavan Vajjah, Catrina Mistry, Matthew Page, Hannah B Edwards, Sandra Garcet, Xuan Li, Benjamin Dizier, A. Maroof, Mark Watling, Assem el Baghdady, Dominique Baeten, Lucian Ionescu, Stevan Shaw

    יצא לאור 2021
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: